Todos Medical partners with Amerimmune Diagnostics on long-COVID biomarker panel

Todos Medical Ltd. (OTCQB:TOMDF) CEO Gerald Commissiong joined Proactive’s Stephen Gunnion with details of an agreement between its Provista Diagnostic laboratory and Amerimmune Diagnostics, a CLIA/CAP certified laboratory with expertise in immune diagnostics and a leader in the field of clinical immunology and immune assessment of acute and long-COVID.

Commissiong said the reference lab agreement with Amerimmune will not only help it advance its Tollovid dietary supplement but will also allow the company to look at other dietary supplement products that long-COVID patients are using and how they impact the immune system in combination.

You might like

© 2022 Stockmark.it The Latest StockMarket News and Interviews